{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:39:18Z","timestamp":1769549958933,"version":"3.49.0"},"reference-count":29,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2010,8,26]]},"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the incidence of late-onset sensorineural hearing loss (SNHL) and study the association between neonatal extracorporeal membrane oxygenation (ECMO) and SNHL in survivors of neonatal ECMO between 9 and 13 years of age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study design<\/jats:title>\n                  <jats:p>Retrospective analysis of medical records of 212 neonatal ECMO survivors treated between 1987 and 1991 to identify children with complete hearing evaluation at 9\u201313 years of age. Patients were categorised into normal hearing (NH) and SNHL groups. Cox proportional-hazard regression analysis was used to take into account the variable age at follow-up and to assess the independent effect of each risk factor for SNHL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Forty-eight of the 212 patients had complete hearing evaluations at 9\u201313 years of age and eight of 48 patients were diagnosed as having SNHL. In two patients, SNHL was first detected between 9 and 13 years. A significant difference between the SNHL and NH groups was found in median 5 min Apgar scores, mean ECMO support duration, proportion of infants with pre-ECMO Paco<jats:sub>2<\/jats:sub> of &lt;30 mm Hg, and pre-ECMO use of furosemide. No differences were found in the mean cumulative dose or duration of diuretic, muscle relaxant or aminoglycoside treatments. The occurrence of clinical seizures before ECMO and the duration of ECMO therapy were independently associated with SNHL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Clinical seizure activity prior to ECMO and the duration of ECMO therapy are independently associated with SNHL. These data confirm that there is an increased incidence of SNHL in neonatal ECMO survivors at 9\u201313 years of age and suggest that SNHL may also present later in childhood in this patient population. Upon recovery from acute respiratory failure and after discharge from the hospital, longitudinal neurodevelopmental follow-up of infants treated with ECMO during the neonatal period is essential.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/adc.2010.186395","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T20:15:24Z","timestamp":1287778524000},"page":"F128-F132","source":"Crossref","is-referenced-by-count":30,"title":["Sensorineural hearing loss at 9\u201313 years of age in children with a history of neonatal extracorporeal membrane oxygenation"],"prefix":"10.1136","volume":"96","author":[{"given":"Melissa","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Nield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Larson-Tuttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Seri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Friedlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"2025090513543722000_96.2.F128.1","unstructured":"Michigan AA . ECMO Registry of the Extracorporeal Life Support Organization (ELSO), 2007."},{"key":"2025090513543722000_96.2.F128.2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.87.4.451","article-title":"Follow-up of infants treated with extracorporeal membrane oxygenation for newborn respiratory failure","volume":"87","author":"Schumacher","year":"1991","journal-title":"Pediatrics"},{"key":"2025090513543722000_96.2.F128.3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3468(85)80230-X","article-title":"Long-term follow-up of infants and children treated with extracorporeal membrane oxygenation (ECMO): a preliminary report","volume":"20","author":"Towne","year":"1985","journal-title":"J Pediatr Surg"},{"key":"2025090513543722000_96.2.F128.4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1542\/peds.87.4.549","article-title":"Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome","volume":"87","author":"Hofkosh","year":"1991","journal-title":"Pediatrics"},{"key":"2025090513543722000_96.2.F128.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70082-X"},{"key":"2025090513543722000_96.2.F128.6","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.122730"},{"key":"2025090513543722000_96.2.F128.7","doi-asserted-by":"publisher","DOI":"10.1016\/0378-3782(95)01711-9"},{"key":"2025090513543722000_96.2.F128.8","first-page":"47","article-title":"Hearing loss in survivors of neonatal extracorporeal membrane oxygenation (ECMO) therapy and high-frequency oscillatory (HFO) therapy","volume":"9","author":"Lasky","year":"1998","journal-title":"J Am Acad Audiol"},{"key":"2025090513543722000_96.2.F128.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5876(97)00095-5"},{"key":"2025090513543722000_96.2.F128.10","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5876(95)01232-X"},{"key":"2025090513543722000_96.2.F128.11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.2.527"},{"key":"2025090513543722000_96.2.F128.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.2.221"},{"key":"2025090513543722000_96.2.F128.13","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1542\/peds.101.1.e4","article-title":"Newborn hearing screening: the great omission","volume":"101","author":"Mehl","year":"1998","journal-title":"Pediatrics"},{"key":"2025090513543722000_96.2.F128.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71047-3"},{"key":"2025090513543722000_96.2.F128.15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/17518429709025856","article-title":"Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation","volume":"1","author":"Cheung","year":"1997","journal-title":"Pediatr Rehabil"},{"key":"2025090513543722000_96.2.F128.16","first-page":"367","article-title":"Sensorineural hearing loss in ECMO survivors. Extracorporeal membraneous oxygenation","volume":"9","author":"Mann","year":"1998","journal-title":"J Am Acad Audiol"},{"key":"2025090513543722000_96.2.F128.17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0247"},{"key":"2025090513543722000_96.2.F128.18","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.103359"},{"key":"2025090513543722000_96.2.F128.19","doi-asserted-by":"publisher","DOI":"10.1177\/088307389701200702"},{"key":"2025090513543722000_96.2.F128.20","doi-asserted-by":"publisher","DOI":"10.1097\/00003446-199810000-00001"},{"key":"2025090513543722000_96.2.F128.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.14.1071"},{"key":"2025090513543722000_96.2.F128.22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2901"},{"key":"2025090513543722000_96.2.F128.23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2333"},{"key":"2025090513543722000_96.2.F128.24","doi-asserted-by":"publisher","DOI":"10.1177\/1084713807304668"},{"key":"2025090513543722000_96.2.F128.25","doi-asserted-by":"publisher","DOI":"10.1159\/000047076"},{"key":"2025090513543722000_96.2.F128.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra012457"},{"key":"2025090513543722000_96.2.F128.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2006.06.012"},{"key":"2025090513543722000_96.2.F128.28","doi-asserted-by":"crossref","unstructured":"Finer NN Barrington KJ . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006;4:CD006285.","DOI":"10.1002\/14651858.CD000399.pub2"},{"key":"2025090513543722000_96.2.F128.29","unstructured":"Van Meurs K Lally KP Peek G eds . ECMO: Extracorporeal Cardiopulmonary Support in Critical Care. Third edition. Ann Arbor, MI: Extracorporeal Life Support Organization 2005:290."}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.2010.186395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T20:54:43Z","timestamp":1757105683000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/adc.2010.186395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,21]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,10]]},"published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1136\/adc.2010.186395"],"URL":"https:\/\/doi.org\/10.1136\/adc.2010.186395","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,21]]}}}